Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by X. Caporis
Prs41 - Cost-Effectiveness of Pirfenidone for the Treatment of Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Evaluating the Annual Cost Per Response Rate of Pirfenidone and Nintedanib for the Treatment of Patients With Idiopathic Pulmonary Fibrosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis
Internal Medicine
Internal Medicine
Medicine
Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis: Nationwide Danish Results
European Clinical Respiratory Journal
Idiopathic Pulmonary Fibrosis and Pirfenidone
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Psy105 - Cost-Utility of Nintedanib Versus Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis: A Belgian Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pirfenidone Should Be Prescribed for Patients With Idiopathic Pulmonary Fibrosis: Table 1
Thorax
Pulmonary
Respiratory Medicine
Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis and More Advanced Lung Function Impairment
Respiratory Medicine
Pulmonary
Respiratory Medicine
Pss32 - Cost-Effectiveness of Brodalumab for the Treatment of Moderate to Severe Plaque Psoriasis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental